Actuate, a global provider of vision-based AI monitoring solutions, has announced the appointment of Ken Francis as CEO.

Francis will lead Actuate’s continued global expansion, strengthen its channel partnerships, and advance its position as a ...

Companies will discuss how Lantern’s AI platform is being leveraged for the identification and development of enrichment ...

About Actuate Therapeutics, Inc. Actuate is a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers. Actuate’s ...

This page features the latest news about the Actuate Therapeutics stock. Actuate to Participate in Lantern's Pharma Webinar on AI-Driven Drug Development Companies will discuss how Lantern's AI ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

stake increases to 5.05% -Signs a regional partnership with the Nasdaq-listed Actuate Corporation, an enterprise reporting applications provider, to collaborate in the Asia Pacific region.